Palisade Bio announced it has appointed Margery Fischbein to its Board of Directors. Fischbein currently serves as Managing Director, Healthcare, for Cassel Salpeter & Co., an independent investment banking firm.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PALI:
- Palisade Bio Appoints Margery Fischbein to its Board of Directors
- Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
- Palisade Bio to sell 615,242 shares at $6.5015 in private placement
- Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
- Palisade Bio ulcerative colitis data promising, says Maxim